| AAs | Amino acids |
| ACR | Acute-cell rejection |
| ALD | Alcoholic liver disease |
| ALT | Alanine transaminase |
| Amp | Ampicillin |
| AR | Acute rejection |
| AST | Aspartate transaminase |
| Atb | Antibody |
| BA | Bile acid |
| BCAA | Branched-chain amino acid |
| BD | Brain-dead |
| BN | Brown Norway |
| BrdU | Bromodeoxyuridine |
| BT | Bacterial translocation |
| CD | Cardiac death |
| CNIs | Calcineurin inhibitors |
| CVD | Cardiovascular disease |
| CYP7A1 | Cytochrome P450 7A1 |
| DCA | Deoxycholic acid |
| DCD | Donation after circulatory death |
| ESLD | End-stage liver disease |
| FGF15 | Fibroblast growth factor 15 |
| FGFR4-KLB | Fibroblast growth factor receptor-4 and its co-receptor klotho-beta |
| FMT | Fecal microbial transplantation |
| FXR | Farnesoid X receptor |
| GC | Glucocorticoids |
| GLP-1 | Glucagon-like peptide 1 |
| GM | Gut microbiota |
| Gln | Glutamine |
| HCC | Hepatocellular carcinoma |
| HGF | Hepatocyte growth factor |
| HWP | Hydrolyzed whey peptide |
| I/R | Ischemia/reperfusion |
| ICAM | Intercellular adhesion molecule |
| ICU | Intensive care unit |
| IL | Interleukin |
| IL-1β | Interleukin-1 β |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| IL-12 | Interleukin-12 |
| IRI | Ischemia/reperfusion injury |
| IS | Immunosuppression |
| Ki67 | Marker of proliferation Ki-67 |
| L | Lewis |
| LCA | Lithocholic acid |
| LD | Linear dichroism |
| LN | Liver transplantation in normal receptors |
| LP-F19 | Lactobacillus paracasei F19 |
| LPS | Lipopolysaccharides |
| LR | Liver regeneration |
| LT | Liver transplantation |
| LTA | Abnormal liver function |
| LTC | Liver transplantation in cirrhotic receptors |
| LTN | Liver transplantation in normal receptors |
| LTN | Normal liver function |
| LTRs | Liver-transplant recipients |
| MDA | Malondialdehyde |
| Met | Metronidazole |
| MP | Methylprednisolone |
| MPA | Mycophenolate |
| Muc2 | Mucin 2 |
| Muc3 | Mucin 3 |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| Neo | Neomycin sulfate |
| NFκB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NKT cell | Natural killer-T cell |
| NLRs | Nod-like receptors |
| NR | Non-rejection group |
| OLT | Orthotropic liver transplant |
| PCNA | Proliferating cell nuclear antigen |
| PGE2 | Prostaglandin E2 |
| PH | Partial hepatectomy |
| RA | All-trans retinoic acid |
| ROS | Reactive oxygen species |
| R TGR5 | Receptor of Takeda G protein-coupled receptor 5 |
| SCFAs | Short-chain fatty acids |
| SD | Sprague Dawley |
| sIgA | Secretory IgA |
| SOD | Superoxide dismutase |
| TGF-β | Transforming growth factor β |
| TGR5 | Takeda G protein-coupled receptor 5 |
| TJ | Tight junction |
| TLR | Toll-like receptor |
| TLR4 | Toll-like receptor 4 |
| TMP-SMX | Trimethoprim-sulfamethoxazole |
| TNF | Tumor necrosis factor |
| TNFα | Tumor necrosis factor α |
| Treg | Regulatory T cells |
| TRF | Time-restricted feeding |
| Vanco | Vancomycin |
| W | Wistar |